Cross-Site Scripting Vulnerability in IBM Aspera Faspex Product
CVE-2025-36226

5.4MEDIUM

Key Information:

Vendor

IBM
Status
Aspera Faspex 5
Vendor
CVE Published:
10 March 2026

What is CVE-2025-36226?

The identified vulnerability in IBM Aspera Faspex 5.0.0 through 5.0.14.3 allows an authenticated user to exploit cross-site scripting. This security flaw permits the insertion of arbitrary JavaScript code within the web user interface, which can compromise the integrity of user sessions. As a result, sensitive information such as credentials may be exposed, raising serious security concerns for users relying on the application.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Aspera Faspex 5 5.0.0 <= 5.0.14.3

References

https://www.ibm.com/support/pages/node/7262816
vendor-advisorypatch

CVSS V3.1

Score:
5.4
Severity:
MEDIUM
Confidentiality:
Low
Integrity:
Low
Availability:
Low
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
Low
User Interaction:
Required
Scope:
Changed

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.